标题
Epstein–Barr virus and multiple sclerosis
作者
关键词
-
出版物
NATURE REVIEWS MICROBIOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-08-05
DOI
10.1038/s41579-022-00770-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Substrate-specific presentation of MHC class I-restricted antigens via autophagy pathway
- (2022) Maria C. Tovar Fernandez et al. CELLULAR IMMUNOLOGY
- Clonally Expanded B Cells in Multiple Sclerosis Bind EBV EBNA1 and GlialCAM
- (2022) Tobias V. Lanz et al. NATURE
- Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
- (2022) Kjetil Bjornevik et al. SCIENCE
- Genetics and functional genomics of multiple sclerosis
- (2022) Woori Kim et al. Seminars in Immunopathology
- Guilty by association: Epstein–Barr virus in multiple sclerosis
- (2022) Amit Bar-Or et al. NATURE MEDICINE
- Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis
- (2022) Alessandro Cagol et al. JAMA Neurology
- Epstein-Barr virus as a driver of multiple sclerosis
- (2022) Ludvig M. Sollid Science Immunology
- Molecular biology of Hodgkin lymphoma
- (2021) Marc A. Weniger et al. LEUKEMIA
- CD27 is required for protective lytic EBV antigen specific CD8+ T cell expansion
- (2021) Yun Deng et al. BLOOD
- The Interaction of Human and Epstein–Barr Virus miRNAs with Multiple Sclerosis Risk Loci
- (2021) Ali Afrasiabi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Defective Epstein-Barr Virus Genomes and Atypical Viral Gene Expression in B-Cell Lines Derived from Multiple Myeloma Patients
- (2021) Fang Lu et al. JOURNAL OF VIROLOGY
- Utilising multi-large omics data to elucidate biological mechanisms within multiple sclerosis genetic susceptibly loci
- (2021) Yuan Zhou et al. Multiple Sclerosis Journal
- Multiple sclerosis: doubling down on MHC
- (2021) Roland Martin et al. TRENDS IN GENETICS
- RNAseq analysis identifies involvement of EBNA2 in PD-L1 induction during Epstein-Barr virus infection of primary B cells
- (2021) Yusuke Yanagi et al. VIROLOGY
- Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus
- (2021) Mickaël Bouvet et al. mBio
- HLA‐DRB1*15:01 is a co‐receptor for Epstein–Barr virus, linking genetic and environmental risk factors for multiple sclerosis
- (2021) Jennifer Menegatti et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- B cells in multiple sclerosis — from targeted depletion to immune reconstitution therapies
- (2021) Maria T. Cencioni et al. Nature Reviews Neurology
- Epigenetic Plasticity Enables CNS-Trafficking of EBV-infected B Lymphocytes
- (2021) Samantha S. Soldan et al. PLoS Pathogens
- EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes
- (2021) Chenhe Su et al. PLoS Pathogens
- The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis
- (2021) Caterina Veroni et al. Frontiers in Immunology
- The interaction of Epstein-Barr virus encoded transcription factor EBNA2 with multiple sclerosis risk loci is dependent on the risk genotype
- (2021) Jeremy Thomas Keane et al. EBioMedicine
- Epstein–Barr Virus in Inborn Immunodeficiency—More Than Infection
- (2021) Ciro Novaes Rosa Lino et al. Cancers
- Immunity to EBV as revealed by immunedeficiencies
- (2021) Benjamin Fournier et al. CURRENT OPINION IN IMMUNOLOGY
- Epstein–Barr virus nuclear antigen 2 extensively rewires the human chromatin landscape at autoimmune risk loci
- (2021) Ted Hong et al. GENOME RESEARCH
- Estimating the global burden of Epstein–Barr virus-related cancers
- (2021) Yide Wong et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
- (2021) Takayuki Murata et al. Viruses-Basel
- The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells
- (2021) Danielle Westhoff Smith et al. mBio
- Epigenetic control of the Epstein-Barr lifecycle
- (2021) Rui Guo et al. Current Opinion in Virology
- Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis
- (2021) Ute-Christiane Meier et al. Frontiers in Immunology
- Genome-wide Identification and Analysis of Splicing QTLs in Multiple Sclerosis by RNA-Seq Data
- (2021) Yijie He et al. Frontiers in Genetics
- Epstein Barr Virus Exploits Genetic Susceptibility to Increase Multiple Sclerosis Risk
- (2021) Fabienne Läderach et al. Microorganisms
- High Levels of Epstein–Barr Virus Nuclear Antigen-1-Specific Antibodies and Infectious Mononucleosis Act Both Independently and Synergistically to Increase Multiple Sclerosis Risk
- (2020) Anna Karin Hedström et al. Frontiers in Neurology
- Epigenetic insights into multiple sclerosis disease progression
- (2020) L. Kular et al. JOURNAL OF INTERNAL MEDICINE
- Tenofovir prodrugs potently inhibit Epstein–Barr virus lytic DNA replication by targeting the viral DNA polymerase
- (2020) Natalia C. Drosu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An atlas on risk factors for multiple sclerosis: a Mendelian randomization study
- (2020) Shuai Yuan et al. JOURNAL OF NEUROLOGY
- Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesis
- (2020) Thomas Sommermann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EBNA-1 titer gradient in families with multiple sclerosis indicates a genetic contribution
- (2020) Julia Y. Mescheriakova et al. Neurology-Neuroimmunology & Neuroinflammation
- Attenuated immune control of Epstein Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA‐DR15
- (2020) Hana Zdimerova et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands
- (2020) Zhe Wang et al. Journal of Neuroimmune Pharmacology
- Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis
- (2020) Michael P. Pender et al. JCI Insight
- An Absence of Epstein–Barr Virus Reactivation and Associations with Disease Activity in People with Multiple Sclerosis Undergoing Therapeutic Hookworm Vaccination
- (2020) Peter A. C. Maple et al. Vaccines
- The association of Epstein‐Barr virus infection with CXCR3 + B‐cell development in multiple sclerosis: impact of immunotherapies
- (2020) Jamie Langelaar et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review
- (2020) Klemens Ruprecht Expert Review of Clinical Immunology
- Mechanism of EBV inducing anti-tumour immunity and its therapeutic use
- (2020) Il-Kyu Choi et al. NATURE
- Epstein–Barr Virus: How Its Lytic Phase Contributes to Oncogenesis
- (2020) Quincy Rosemarie et al. Microorganisms
- MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo
- (2019) Anita Murer et al. mBio
- Epstein-Barr virus strain variation and cancer
- (2019) Teru Kanda et al. CANCER SCIENCE
- Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility
- (2019) Ali Afrasiabi et al. Genome Medicine
- Latency and lytic replication in Epstein–Barr virus-associated oncogenesis
- (2019) Christian Münz NATURE REVIEWS MICROBIOLOGY
- Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk
- (2019) Katarina Tengvall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Global Landscape of EBV-Associated Tumors
- (2019) Claire Shannon-Lowe et al. Frontiers in Oncology
- Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism
- (2019) Barbara Serafini et al. JOURNAL OF VIROLOGY
- Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15
- (2019) Lukas Simon Enz et al. Neurology-Neuroimmunology & Neuroinflammation
- Pediatric multiple sclerosis: a review
- (2018) Raed Alroughani et al. BMC Neurology
- Primary Epstein-Barr virus infection
- (2018) Samantha K. Dunmire et al. JOURNAL OF CLINICAL VIROLOGY
- Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis
- (2018) Caterina Veroni et al. Journal of Neuroinflammation
- Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells
- (2018) Bryan Ceronie et al. JOURNAL OF NEUROLOGY
- HLA alleles modulate EBV viral load in multiple sclerosis
- (2018) Simone Agostini et al. Journal of Translational Medicine
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Epstein−Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas
- (2018) Eleni Anastasiadou et al. LEUKEMIA
- Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity
- (2018) John B. Harley et al. NATURE GENETICS
- Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells
- (2018) Asma Hassani et al. PLoS One
- DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis
- (2018) Lara Kular et al. Nature Communications
- Multiple Sclerosis Pathology
- (2018) Hans Lassmann Cold Spring Harbor Perspectives in Medicine
- Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis
- (2018) Ivan Jelcic et al. CELL
- Epstein-Barr virus associated smooth muscle tumors in solid organ transplant recipients: Incidence over 31 years at a single institution and review of the literature
- (2018) Ryan J. Stubbins et al. Transplant Infectious Disease
- B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro
- (2017) Robert P. Lisak et al. JOURNAL OF NEUROIMMUNOLOGY
- Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication
- (2017) Andrea Bilger et al. Oncotarget
- EBI2 Is Highly Expressed in Multiple Sclerosis Lesions and Promotes Early CNS Migration of Encephalitogenic CD4 T Cells
- (2017) Florian Wanke et al. Cell Reports
- Epstein–Barr virus and multiple sclerosis: Updating Pender's hypothesis
- (2017) Martin Laurence et al. Multiple Sclerosis and Related Disorders
- Infectious mononucleosis and multiple sclerosis – Updated review on associated risk
- (2017) Sharaf Sheik-Ali Multiple Sclerosis and Related Disorders
- Chronic Active Epstein–Barr Virus Disease
- (2017) Hiroshi Kimura et al. Frontiers in Immunology
- Peer review is not broken
- (2017) Nature Microbiology
- Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis
- (2017) David Baker et al. EBioMedicine
- Elucidation of Exosome Migration Across the Blood–Brain Barrier Model In Vitro
- (2016) Claire C. Chen et al. Cellular and Molecular Bioengineering
- High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients
- (2016) Michael Hecker et al. MOLECULAR & CELLULAR PROTEOMICS
- Hairy leukoplakia; lessons learned: 30-plus years
- (2016) JS Greenspan et al. ORAL DISEASES
- Sensing of latent EBV infection through exosomal transfer of 5′pppRNA
- (2016) S. Rubina Baglio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention—An Update
- (2016) Kassandra Munger et al. SEMINARS IN NEUROLOGY
- Variation in the Human Immune System Is Largely Driven by Non-Heritable Influences
- (2015) Petter Brodin et al. CELL
- IFN-β and multiple sclerosis: From etiology to therapy and back
- (2015) V. Annibali et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Genomic imprinting: A missing piece of the Multiple Sclerosis puzzle?
- (2015) Sabrina Ruhrmann et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Update on Epstein-Barr virus and gastric cancer (Review)
- (2015) AYA SHINOZAKI-USHIKU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The immunogenetics of multiple sclerosis: A comprehensive review
- (2015) Jill A. Hollenbach et al. JOURNAL OF AUTOIMMUNITY
- Susceptibility Genes for Multiple Sclerosis Identified in a Gene-Based Genome-Wide Association Study
- (2015) Xiang Lin et al. Journal of Clinical Neurology
- Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis
- (2015) Caterina Veroni et al. Journal of Neuroinflammation
- Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins
- (2015) Gijsbert P van Nierop et al. Multiple Sclerosis Journal
- Epstein-Barr virus genetic variants are associated with multiple sclerosis
- (2015) R. Mechelli et al. NEUROLOGY
- Gammaherpesvirus Infection of Human Neuronal Cells
- (2015) Hem Chandra Jha et al. mBio
- The Incubation Period of Primary Epstein-Barr Virus Infection: Viral Dynamics and Immunologic Events
- (2015) Samantha K. Dunmire et al. PLoS Pathogens
- Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins
- (2015) Gijsbert P van Nierop et al. Multiple Sclerosis Journal
- Involvement of CD8+ T Cells in Multiple Sclerosis
- (2015) Marion Salou et al. Frontiers in Immunology
- EBNA2 Binds to Genomic Intervals Associated with Multiple Sclerosis and Overlaps with Vitamin D Receptor Occupancy
- (2015) Vito A. G. Ricigliano et al. PLoS One
- Role for early-differentiated natural killer cells in infectious mononucleosis
- (2014) T. Azzi et al. BLOOD
- Genome-Wide Analysis of Wild-Type Epstein–Barr Virus Genomes Derived from Healthy Individuals of the 1000 Genomes Project
- (2014) Gabriel Santpere et al. Genome Biology and Evolution
- Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
- (2014) Ludwig Kappos et al. LANCET NEUROLOGY
- Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis
- (2014) Michael P Pender et al. Multiple Sclerosis Journal
- Epstein–Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis
- (2014) Michael P Pender et al. Multiple Sclerosis Journal
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- G-quadruplexes regulate Epstein-Barr virus–encoded nuclear antigen 1 mRNA translation
- (2014) Pierre Murat et al. Nature Chemical Biology
- Epigenetics of Multiple Sclerosis: An Updated Review
- (2014) Cem İsmail Küçükali et al. NEUROMOLECULAR MEDICINE
- Quantitative Detection of Epstein-Barr Virus DNA in Cerebrospinal Fluid and Blood Samples of Patients with Relapsing-Remitting Multiple Sclerosis
- (2014) Clementina E. Cocuzza et al. PLoS One
- Epigenetic regulation of EBV persistence and oncogenesis
- (2014) Italo Tempera et al. SEMINARS IN CANCER BIOLOGY
- Modelling the structure of full-length Epstein–Barr virus nuclear antigen 1
- (2014) Mushtaq Hussain et al. VIRUS GENES
- mRNA Structural Constraints on EBNA1 Synthesis Impact on In Vivo Antigen Presentation and Early Priming of CD8+ T Cells
- (2014) Judy T. Tellam et al. PLoS Pathogens
- Age-Specific Prevalence of Epstein–Barr Virus Infection Among Individuals Aged 6–19 Years in the United States and Factors Affecting Its Acquisition
- (2013) Henry H. Balfour et al. JOURNAL OF INFECTIOUS DISEASES
- Oligoclonal bands in multiple sclerosis reactive against two herpesviruses and association with magnetic resonance imaging findings
- (2013) JO Virtanen et al. Multiple Sclerosis Journal
- Epstein-Barr virus in oral shedding of children with multiple sclerosis
- (2013) C. Yea et al. NEUROLOGY
- Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection
- (2013) Obinna Chijioke et al. Cell Reports
- Messenger RNA Sequence Rather than Protein Sequence Determines the Level of Self-synthesis and Antigen Presentation of the EBV-encoded Antigen, EBNA1
- (2013) Judy T. Tellam et al. PLoS Pathogens
- Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis
- (2013) Daniela F. Angelini et al. PLoS Pathogens
- Peptide matching between Epstein-Barr virus and human proteins
- (2013) Giovanni Capone et al. Pathogens and Disease
- Epstein-Barr Virus Genotypes and Strains in Central Nervous System Demyelinating Disease and Epstein-Barr Virus-Related Illnesses in Australia
- (2012) Meav-Lang J. Lay et al. INTERVIROLOGY
- B-Cell Enrichment and Epstein-Barr Virus Infection in Inflammatory Cortical Lesions in Secondary Progressive Multiple Sclerosis
- (2012) Roberta Magliozzi et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- The initiation and prevention of multiple sclerosis
- (2012) Alberto Ascherio et al. Nature Reviews Neurology
- The EBV Immunoevasins vIL-10 and BNLF2a Protect Newly Infected B Cells from Immune Recognition and Elimination
- (2012) Simon Jochum et al. PLoS Pathogens
- Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
- (2011) E. Doubrovina et al. BLOOD
- Decreased CD8+T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes
- (2011) Michael P Pender et al. BMC Neurology
- Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria
- (2011) H. Lassmann et al. BRAIN
- CD8 T cell deficiency impairs control of Epstein–Barr virus and worsens with age in multiple sclerosis: Figure 1
- (2011) Michael P Pender et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Negative association of Epstein-Barr virus or herpes simplex virus-1 with tumefactive central nervous system inflammatory demyelinating disease
- (2011) Takao Kiriyama et al. JOURNAL OF NEUROVIROLOGY
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- Anti-Epstein–Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel
- (2011) KL Munger et al. Multiple Sclerosis Journal
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
- (2011) Stephen Sawcer et al. NATURE
- Association of innate immune activation with latent Epstein-Barr virus in active MS lesions
- (2011) J. S. Tzartos et al. NEUROLOGY
- The myelin basic protein gene in multiple sclerosis: identification of discrete alleles of a 1.3 kb tetranucleotide repeat sequence
- (2010) B. He et al. ACTA NEUROLOGICA SCANDINAVICA
- Epstein-Barr virus antibodies in serum and cerebrospinal fluid from Multiple sclerosis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Amyotrophic Lateral Sclerosis
- (2010) V. Nociti et al. JOURNAL OF NEUROIMMUNOLOGY
- Cerebrospinal BAFF and Epstein–Barr virus-specific oligoclonal bands in multiple sclerosis and other inflammatory demyelinating neurological diseases
- (2010) Diego Franciotta et al. JOURNAL OF NEUROIMMUNOLOGY
- Epstein-Barr Virus Latent Infection and BAFF Expression in B Cells in the Multiple Sclerosis Brain: Implications for Viral Persistence and Intrathecal B-Cell Activation
- (2010) Barbara Serafini et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Strains of Epstein-Barr virus infecting multiple sclerosis patients
- (2010) RM Brennan et al. Multiple Sclerosis Journal
- Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis
- (2010) S. A. Sargsyan et al. NEUROLOGY
- The Essential Role of Epstein-Barr Virus in the Pathogenesis of Multiple Sclerosis
- (2010) Michael P. Pender NEUROSCIENTIST
- Epstein–Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-β
- (2010) Gretchen L. Bentz et al. VIROLOGY
- Epstein Barr Virus-Encoded EBNA1 Interference with MHC Class I Antigen Presentation Reveals a Close Correlation between mRNA Translation Initiation and Antigen Presentation
- (2010) Sebastien Apcher et al. PLoS Pathogens
- Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
- (2009) H. E. Heslop et al. BLOOD
- Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis
- (2009) Laura A. N. Peferoen et al. BRAIN
- Epstein–Barr virus infection is not a characteristic feature of multiple sclerosis brain
- (2009) Simon N. Willis et al. BRAIN
- Upregulation of Immunoglobulin-related Genes in Cortical Sections from Multiple Sclerosis Patients
- (2009) Øivind Torkildsen et al. BRAIN PATHOLOGY
- Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
- (2009) Till Strowig et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20
- (2009) Melanie Bahlo et al. NATURE GENETICS
- Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci
- (2009) Philip L De Jager et al. NATURE GENETICS
- Immune responses to EBNA1: Biomarkers in MS?
- (2009) J. D. Lunemann et al. NEUROLOGY
- EBV BMRF-2 facilitates cell-to-cell spread of virus within polarized oral epithelial cells
- (2009) Jianqiao Xiao et al. VIROLOGY
- Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis
- (2008) Samantha Jilek et al. BRAIN
- EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2
- (2008) Jan D. Lünemann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
- (2008) Benjamin M Segal et al. LANCET NEUROLOGY
- Quantitative PCR for Epstein–Barr virus DNA and RNA in multiple sclerosis
- (2008) JW Lindsey et al. Multiple Sclerosis Journal
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started